These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1409510)

  • 1. [Combined chemotherapy of toxic hepatitis in patients with pulmonary tuberculosis].
    Frolov VM; Peresadin NA; Pustovoĭ IuG
    Probl Tuberk; 1992; (5-6):30-1. PubMed ID: 1409510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of patients with destructive pulmonary tuberculosis with chemotherapeutic preparations combined with sodium nucleinate].
    Kharakter ZhZ; Pavlenko AV
    Probl Tuberk; 1989; (4):27-30. PubMed ID: 2734260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of treating patients with destructive pulmonary tuberculosis with liver involvement].
    Novozhylova IO
    Lik Sprava; 1998; (7):121-3. PubMed ID: 10050479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are antitubercular drugs prescribed correctly and scientifically?
    Sahoo RC
    J Assoc Physicians India; 1994 Apr; 42(4):349-50. PubMed ID: 7860579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of the treatment of patients with pulmonary tuberculosis by the short-term chemotherapy method with reference to the side effects of the drugs].
    Westfal I; Spychalski W; Szelerska-Twardosz H; Grzegorzewska A; Ryszewski W
    Pneumonol Pol; 1988 Apr; 56(4):163-5. PubMed ID: 3412967
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction.
    Yew WW; Chau CH; Wong PC; Lee J; Wong CF; Cheung SW; Chan CY; Cheng AF
    Drugs Exp Clin Res; 1995; 21(2):79-83. PubMed ID: 7555613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reamberin in tuberculosis chemotherapy and its effect on liver function].
    Antibiot Khimioter; 2013; 58(3-4):33-6. PubMed ID: 24640150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lomefloxacin in phthisiatric practice].
    Grishin VK; Polunina TE
    Antibiot Khimioter; 1998; 43(10):17-8. PubMed ID: 9825104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of 172 patients with hepatic injury caused by antituberculosis drugs].
    Cheng SQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):571. PubMed ID: 15387923
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinico-immunological variants of drug-induced toxic hepatitis in pulmonary tuberculosis patients].
    Frolov VM; Peresadin NA; Petrunia AM
    Probl Tuberk; 1993; (6):17-9. PubMed ID: 8290522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of the plant hepatoprotector Galstena tuberculostatics-induced hepatic lesions: experimental and clinical study].
    Katikova OIu; Asanov BM; Vize-Khripunova MA; Burba EN; Ruzov VI
    Probl Tuberk; 2002; (4):32-6. PubMed ID: 12125250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatotoxicity to different antituberculosis drug combinations.
    Aziz S; Agha F; Hassan R; Fairoz SA; Hassan K
    J Pak Med Assoc; 1990 Dec; 40(12):290-4. PubMed ID: 2126569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1988 Apr; 30(763):43-4. PubMed ID: 3352531
    [No Abstract]   [Full Text] [Related]  

  • 18. Short communication: antituberculosis drug-induced hepatotoxicity is unexpectedly low in HIV-infected pulmonary tuberculosis patients in Malawi.
    Tostmann A; Boeree MJ; Harries AD; Sauvageot D; Banda HT; Zijlstra EE
    Trop Med Int Health; 2007 Jul; 12(7):852-5. PubMed ID: 17596252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of the treatment of patients with pulmonary tuberculosis using a liver protector zixoryn].
    Mezhebovskiĭ VR
    Probl Tuberk; 1990; (10):32-5. PubMed ID: 2080156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of the preparation Wobenzym on the antioxidant protection indices and on the functional-morphological properties of the erythrocytes in a toxic lesion of the liver].
    Kolomoiets MIu; Shorikov IeI
    Lik Sprava; 1999 Jul; (5):124-8. PubMed ID: 10822699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.